A Preliminary Study Evaluating the Safety and Efficacy of Bumetanide, an NKCC1 Inhibitor, in Patients with Drug-Resistant Epilepsy.Published in:2019By:Gharaylou, Zeinab;Hadjighassem, Mahmoudreza;Tafakhori, Abbas;Agah, Elmira;Aghamollaii, Vajihe;Kebriaeezadeh, AbbasPublication type:journal article